ID   HT-29R13
AC   CVCL_4V27
DR   cancercelllines; CVCL_4V27
DR   Wikidata; Q54896534
RX   PubMed=7903534;
RX   PubMed=8324877;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:27504; Mitomycin C (MMC; MitC).
CC   Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 05-10-23; Version: 17
//
RX   PubMed=7903534; DOI=10.1016/0006-2952(93)90642-A;
RA   Perry R.R., Kang Y., Greaves B.R.;
RT   "Biochemical characterization of a mitomycin C resistant colon cancer
RT   cell line variant.";
RL   Biochem. Pharmacol. 46:1999-2005(1993).
//
RX   PubMed=8324877; DOI=10.1007/BF00686181;
RA   Perry R.R., Greaves B.R., Kang Y.;
RT   "Development and initial characterization of a mitomycin C-resistant
RT   colon cancer cell line variant.";
RL   Cancer Chemother. Pharmacol. 32:326-328(1993).
//